The immune system depends on molecular alarms that detect danger inside cells. One of these alarms is STING, short for ...
The development of STING agonists for cancer has been beset by safety issues and discontinued programmes, but Daiichi Sankyo is hoping a new antibody-drug conjugate (ADC) could succeed where others ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results